AB

AbClon Inc.

Develops antibody therapeutics and CAR-T for oncology and provides CRO services.

174900 | KO

Overview

Corporate Details

ISIN(s):
KR7174900001
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로 285 에이스트윈타워 1차 1401호, 구로구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

AbClon Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel antibody-based therapeutics, primarily for oncology. The company's core technological assets include the CAR-T platform for personalized cancer immunotherapies, the NEST (Novel Epitope Screening Technology) platform for discovering antibodies against unique epitopes on disease proteins, and the AffiMab platform for the agile development of bispecific antibodies. These platforms are designed to address refractory diseases by creating treatments with novel therapeutic effects. In addition to its therapeutic pipeline, AbClon provides contract research organization (CRO) services, including antibody production and purification.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-27 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.3 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-11 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.5 KB
2025-07-14 00:00
Share Issue/Capital Change
전환주식의전환가액조정 (전환우선주)
Korean 11.3 KB
2025-05-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 79.7 KB
2025-05-21 00:00
M&A Activity
[기재정정]투자판단관련주요경영사항 (CART 세포치료제 `AT101` 기술이전 계약 체결)
Korean 18.3 KB
2025-05-20 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.3 KB
2025-05-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.1 KB
2025-05-19 00:00
Share Issue/Capital Change
전환주식의전환가액조정
Korean 12.0 KB
2025-05-15 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 895.6 KB
2025-05-09 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 42.1 KB
2025-05-09 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 45.1 KB
2025-04-28 00:00
Audit Report / Information
[기재정정]감사보고서제출
Korean 29.9 KB
2025-04-28 00:00
Audit Report / Information
[기재정정]사업보고서 (2023.12)
Korean 522.3 KB

Automate Your Workflow. Get a real-time feed of all AbClon Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbClon Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AbClon Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS
Adaptive Biotechnologies Corp Logo
Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.
United States of America
ADPT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland
ADI1
Adeia Inc. Logo
Invents and licenses foundational IP for the media and semiconductor industries.
United States of America
ADEA
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea
397810
Aditxt, Inc. Logo
Acquires and develops biotech for autoimmunity, cancer detection, and neuro diagnostics.
United States of America
ADTX
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France
ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany
APM
Adtraction Group AB Logo
A partner marketing platform driving online sales for brands with a performance-based model.
Sweden
ADTR

Talk to a Data Expert

Have a question? We'll get back to you promptly.